about
Short communication: Molecular epidemiology, phylogeny, and phylodynamics of CRF63_02A1, a recently originated HIV-1 circulating recombinant form spreading in Siberia.Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.Design and evaluation of optimized artificial HIV-1 poly-T cell-epitope immunogensRational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses.Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen.Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine design, immunogenicity and toxicity studies.Construction of artificial virus-like particles exposing HIV epitopes, and the study of their immunogenic properties.Detection of spring viremia of carp virus isolates by hybridization with non-radioactive probes and amplification by polymerase chain reaction.Localization of the amino terminus of the hepatitis B virus core antigen within the core particle.P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.P19-13. Recombinant proteins carrying peptide mimics of HIV-1.Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen.Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.Design of specific immunogens using filamentous phage as the carrier.CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1.P19-36. Preclinical study of CombiHIVvac vaccineInserting foreign peptides into the major coat protein of bacteriophage M13Design of immunogens as components of a new generation of molecular vaccinesA synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins
P50
Q34116894-5C59C6D1-4CD8-44B1-9416-CA7E7F6B1561Q34160874-44C3016C-D313-464C-B474-B0D6957F2AFAQ35191547-99BB5039-14B8-48F4-AF1F-6257DA17D11BQ35192275-ED0D5A78-E63C-4114-85C9-D08CF0D30E0CQ39734252-8913C0D8-2B2A-4286-B860-BDF61B39D49AQ41834074-31B2BA5C-D05C-4F88-9DBA-BE875A1310E1Q45405375-6C1D5A36-93B7-4B55-9773-467CCC7CA3E1Q45729525-77520A20-7747-400E-898E-716818DFF629Q45746919-C81FD8C3-4886-4DDD-9B50-017BA330607AQ45758135-1F5B5F38-0CA4-467B-9137-A7A65B8288E1Q46424565-481E42A2-7129-4246-8EEB-1B84B2AABA8EQ46812396-5494C3DB-945D-47DF-8136-8760C09FAFC9Q47805143-0AEDE032-3824-4215-A59F-5B9E5605BEC0Q47805167-783B3F56-08F5-4947-B701-AC836C2DF00DQ54237990-0B78F278-884F-4B0C-85E6-A0E44AA2D6F1Q54436931-5CB173B0-3ABD-478B-B4E8-675550658775Q59219893-369BAD8A-C8AF-4E74-B5CB-18957B07ED3DQ68111130-8E05D3F1-D7E4-4B0A-A7F8-B5A43F347BCAQ71284351-2509B61B-6399-4C29-9E34-FBAD504C647BQ81297616-AAC6970E-4AB9-47A0-BE43-6EF21B96BA29
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alexander A. Ilyichev
@ast
Alexander A. Ilyichev
@en
Alexander A. Ilyichev
@es
Alexander A. Ilyichev
@nl
Alexander Alexejewitsch Iljitschow
@de
Александр Алексеевич Ильичёв
@ru
type
label
Alexander A. Ilyichev
@ast
Alexander A. Ilyichev
@en
Alexander A. Ilyichev
@es
Alexander A. Ilyichev
@nl
Alexander Alexejewitsch Iljitschow
@de
Александр Алексеевич Ильичёв
@ru
altLabel
Aleksandr Alekseyevich Ilyichyov
@en
Aleksandr Ilyichyov
@en
Alexander Iljitschow
@de
Alexander Ilyichev
@en
Il'ichev
@en
Ilitchev
@en
Ilychev Ilichev
@en
prefLabel
Alexander A. Ilyichev
@ast
Alexander A. Ilyichev
@en
Alexander A. Ilyichev
@es
Alexander A. Ilyichev
@nl
Alexander Alexejewitsch Iljitschow
@de
Александр Алексеевич Ильичёв
@ru
P1053
B-1327-2012
P106
P1153
7006402361
P21
P31
P3829
P496
0000-0001-5356-0843